DRKS00004860招募中不适用
Psycho-oncological consultation and treatment in the context of Comprehensive Cancer’s Centers (CCC): A multicenter study of evaluation needs, indications, use, and evaluation of oncological care - CCC-MC
Klinik für TumorbiologiePsychosoziale Abteilung0 个研究点目标入组 1,320 人开始时间: 2013年5月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •* Patients with tumor without selection of diagnostic groups, tumor status, or other characteristics
- •* minimum age 18 years
- •* with/under curative or palliative treatment
- •* sufficient german language.
排除标准
- •* Signs/Indication of acute psychiatric illness (schizophrenia, depression)
- •* Signs/Indication of chronic neurological disease (e.g. dementia).
研究者
相似试验
招募中
不适用
Psychooncological brief therapeutic intervention for parents of adolescent and young adults (AYA) with hematological malignanciesmaladaptive copingC81-C96Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissueDRKS00004259niversitätsklinik für Hämatologie und Onkologie160
已完成
2 期
Intersectoral psycho-oncological help for caregivers and patients with cancerDistress in oncological patients and their relativesDyadic Coping in oncological patients and their relativesDRKS00025936niversitätsklinikum Düsseldorf138
招募中
不适用
Effectiveness of psycho-oncological care for relatives of lung cancer patientsung cancerDRKS00030077niversitätsklinikum Würzburg, Comprehensive Cancer Center Mainfranken88
已完成
4 期
Digital, psyho-oncological Support for cancer patients during and after therapy to improve health-related quality of lifeC00-C97Malignant neoplasmsDRKS00022996Medizinische Psychologie und Medizinische Soziologie Uniklinik Leipzig548
已完成
2 期
Evaluation of the effect of psycho-oncological intervention on well-being of patients with advanced prostate cancer on LHRH analogs and their partners. A randomized controlled pilot study.coping / adaptation1002765610001302NL-OMON39520Ipsen Pharmaceuticals50